Bundamedik Tbk PT
IDX:BMHS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
236
360
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bundamedik Tbk PT
Balance Sheet
Balance Sheet Decomposition
Bundamedik Tbk PT
| Current Assets | 1.4T |
| Cash & Short-Term Investments | 1.2T |
| Receivables | 149.8B |
| Other Current Assets | 119.6B |
| Non-Current Assets | 2.3T |
| Long-Term Investments | 83.2B |
| PP&E | 2.1T |
| Intangibles | 94.8B |
| Other Non-Current Assets | 92.8B |
| Current Liabilities | 808.5B |
| Accounts Payable | 45.4B |
| Accrued Liabilities | 27.5B |
| Short-Term Debt | 701.4B |
| Other Current Liabilities | 34.1B |
| Non-Current Liabilities | 1.4T |
| Long-Term Debt | 784.1B |
| Other Non-Current Liabilities | 584.6B |
Balance Sheet
Bundamedik Tbk PT
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
98 879
|
90 657
|
619 379
|
818 112
|
590 555
|
170 822
|
|
| Cash |
98 879
|
90 657
|
619 379
|
818 112
|
590 555
|
170 822
|
|
| Short-Term Investments |
3 754
|
9 598
|
5 607
|
33 774
|
47 367
|
457 002
|
|
| Total Receivables |
85 903
|
99 049
|
160 071
|
208 672
|
150 547
|
137 160
|
|
| Accounts Receivables |
37 913
|
61 849
|
123 131
|
156 760
|
114 644
|
110 469
|
|
| Other Receivables |
47 989
|
37 199
|
36 940
|
51 912
|
35 904
|
26 691
|
|
| Inventory |
10 286
|
16 229
|
18 986
|
38 895
|
39 449
|
42 198
|
|
| Other Current Assets |
18 758
|
15 565
|
11 691
|
31 653
|
59 911
|
61 864
|
|
| Total Current Assets |
217 580
|
231 097
|
815 734
|
1 131 106
|
887 830
|
869 046
|
|
| PP&E Net |
988 015
|
1 124 340
|
1 273 019
|
1 559 679
|
1 844 114
|
1 966 240
|
|
| PP&E Gross |
988 015
|
1 124 340
|
1 273 019
|
1 559 679
|
1 844 114
|
1 966 240
|
|
| Accumulated Depreciation |
202 776
|
241 109
|
269 235
|
348 152
|
491 520
|
582 125
|
|
| Goodwill |
0
|
0
|
0
|
50 812
|
94 794
|
94 794
|
|
| Long-Term Investments |
6 500
|
22 765
|
48 543
|
21 495
|
78 690
|
83 196
|
|
| Other Long-Term Assets |
29 056
|
22 556
|
25 241
|
50 605
|
33 183
|
69 887
|
|
| Other Assets |
0
|
0
|
0
|
50 812
|
94 794
|
94 794
|
|
| Total Assets |
1 241 151
N/A
|
1 400 758
+13%
|
2 162 537
+54%
|
2 813 697
+30%
|
2 938 610
+4%
|
3 083 162
+5%
|
|
| Liabilities | |||||||
| Accounts Payable |
89 227
|
74 678
|
120 125
|
119 160
|
91 788
|
55 771
|
|
| Accrued Liabilities |
12 303
|
9 362
|
28 134
|
43 396
|
27 025
|
30 345
|
|
| Short-Term Debt |
0
|
0
|
391 718
|
391 718
|
391 718
|
411 753
|
|
| Current Portion of Long-Term Debt |
50 968
|
74 887
|
34 427
|
50 920
|
81 739
|
19 770
|
|
| Other Current Liabilities |
45 303
|
99 655
|
108 812
|
131 304
|
51 592
|
51 993
|
|
| Total Current Liabilities |
197 801
|
258 582
|
683 216
|
736 497
|
643 862
|
569 632
|
|
| Long-Term Debt |
482 690
|
443 214
|
386 009
|
229 437
|
457 963
|
688 431
|
|
| Deferred Income Tax |
0
|
0
|
115
|
136
|
18
|
0
|
|
| Minority Interest |
37 450
|
47 012
|
54 462
|
245 476
|
212 082
|
210 223
|
|
| Other Liabilities |
28 431
|
33 368
|
43 498
|
51 410
|
28 535
|
25 064
|
|
| Total Liabilities |
746 373
N/A
|
782 176
+5%
|
1 167 300
+49%
|
1 262 957
+8%
|
1 342 459
+6%
|
1 493 349
+11%
|
|
| Equity | |||||||
| Common Stock |
1 000
|
1 000
|
150 000
|
172 068
|
172 068
|
172 068
|
|
| Retained Earnings |
24 272
|
17 049
|
83 742
|
242 067
|
303 295
|
297 851
|
|
| Additional Paid In Capital |
74 441
|
74 441
|
74 441
|
449 168
|
437 383
|
437 383
|
|
| Unrealized Security Profit/Loss |
448 094
|
564 306
|
690 499
|
690 499
|
690 499
|
690 499
|
|
| Other Equity |
4 485
|
4 115
|
3 445
|
3 063
|
7 095
|
7 988
|
|
| Total Equity |
494 778
N/A
|
618 582
+25%
|
995 237
+61%
|
1 550 740
+56%
|
1 596 151
+3%
|
1 589 813
0%
|
|
| Total Liabilities & Equity |
1 241 151
N/A
|
1 400 758
+13%
|
2 162 537
+54%
|
2 813 697
+30%
|
2 938 610
+4%
|
3 083 162
+5%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
8 541
|
8 541
|
8 541
|
8 603
|
8 603
|
8 603
|
|
You don't have any saved screeners yet
